Outcome of limited‐stage peripheral T‐Cell lymphoma after CHOP(−like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology group.

Autor: Ludvigsen Al‐Mashhadi, Ahmed, Cederleuf, Henrik, Kuhr Jensen, Rasmus, Holm Nielsen, Torsten, Bjerregård Pedersen, Martin, Bech Mortensen, Thomas, Relander, Thomas, Jerkeman, Mats, Ortved Gang, Anne, Kristensen, Anne Louise, Roost Clausen, Michael, de Nully Brown, Peter, Tang Severinsen, Marianne, Jakobsen, Lasse Hjort, Ellin, Fredrik, El‐Galaly, Tarec Christoffer

Publikováno v: American Journal of Hematology; Mar2023, Vol. 98 Issue 3, p388-397, 10p

P1177: ROUTINE CLINICAL FOLLOW-UP FOR RELAPSE DETECTION IN PATIENTS WITH LARGE B-CELL LYMPHOMA AFTER FIRST-LINE TREATMENT – DOES NOT MEET THE AIMS. A RETROSPECTIVE DANISH MULTICENTER STUDY.

Autor: Lassen, Therese, Holm Nielsen, Torsten, Ortved Gang, Anne, Kongsgaard Nielsen, Lene, Von Heymann, Annika, Johansen, Christoffer, Møller Pedersen, Lars

Publikováno v: HemaSphere; 2023 Supplement 3, Vol. 7, pe1107532-e1107532, 1p

Outcome of limited-stage peripheral T-Cell lymphoma after CHOP(-like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology group.

Autor: Ludvigsen Al-Mashhadi A; Department of Haematology, Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.; Department of Haematology, Aarhus University Hospital, Aarhus, Denmark., Cederleuf H; Department of Oncology, Skane University Hospital, Lund, Sweden., Kuhr Jensen R; Department of Haematology, Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark., Holm Nielsen T; Department of Haematology, Rigshospitalet, Copenhagen, Denmark.; Danish Medicines Agency, Copenhagen, Denmark., Bjerregård Pedersen M; Department of Haematology, Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.; Department of Haematology, Aarhus University Hospital, Aarhus, Denmark., Bech Mortensen T; Department of Haematology, Odense University Hospital, Odense, Denmark., Relander T; Department of Oncology, Skane University Hospital, Lund, Sweden., Jerkeman M; Department of Oncology, Skane University Hospital, Lund, Sweden., Ortved Gang A; Department of Haematology, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Kristensen AL; Department of Haematology, Zealand University Hospital, Roskilde, Denmark., Roost Clausen M; Department of Haematology, Vejle Hospital, Vejle, Denmark., de Nully Brown P; Department of Haematology, Rigshospitalet, Copenhagen, Denmark., Tang Severinsen M; Department of Haematology, Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark., Jakobsen LH; Department of Haematology, Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark., Ellin F; Department of Oncology, Skane University Hospital, Lund, Sweden., El-Galaly TC; Department of Haematology, Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.; Department of Haematology, Odense University Hospital, Odense, Denmark.

Publikováno v: American journal of hematology [Am J Hematol] 2023 Mar; Vol. 98 (3), pp. 388-397. Date of Electronic Publication: 2023 Jan 01.